ODYSSION
Live / Registered — Registered (as of 06 Feb 2024)
What this means for you
Registered since 06 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79352298
- Registration number
- 7296103
- Mark type
- Stylized text
- Filed
- 24 May 2022
- Published for opposition
- 21 Nov 2023
- Registered
- 06 Feb 2024
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 001 — Chemicals: Reagents for use in medical research and scientific research being biological analysis; proteins for use in the manufacture of pharmaceuticals and reagents; proteins in raw material form for use in medical research; cells, cell lines, and cell cultures, all being cells for clinical laboratory use, for use in the production of proteins for therapeutic use
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations and substances for the treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; biopharmaceutical preparations and substances for treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; chemical, biochemical and biological preparations for medical and veterinary purposes for the treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; cells, cell lines, and cell cultures, all being cells for medical use, for use in the production of proteins for therapeutic use; reagents for medical use, namely, proteins being medical therapeutic reagents; therapeutic antibodies; vaccines
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research and design relating thereto in the field of analytical sciences, biophysics, chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; laboratory research services in the field of analytical sciences, biophysics, chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; medical and pharmacological research services; scientific research, namely, scientific analysis and testing being measurement of substances in the field of analytical sciences, biophysics, chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; scientific analysis and measurement of molecules and characteristics in the field of analytical sciences, biophysics, chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; bioanalysis services; scientific imaging services; biochemical analysis; scientific research and development services; medical research and medical development services in the field of immunology, genetic conditions, oncology, immuno-oncology, ophthalmology, haematology, neurology, respiratory diseases, metabolic conditions, infectious diseases and cardiovascular diseases; pharmaceutical research and development services; biological research and analysis; biomedical research services; biotechnological research, namely, biotechnology scientific testing, in the biotechnical, biomedical and pharmaceutical fields; chemical research and analysis; research and development of new products for others in the biotechnical, biomedical and pharmaceutical fields; pharmaceutical research and development for the pharmaceutical industry; research and development of vaccines and medicines; scientific research and development services in the field of antibodies; scientific research and development services in the field of antibody technology; scientific research and development services in the field of immunology; medical laboratory services; research of pharmaceuticals; research relating to molecular sciences; research relating to pharmaceuticals; biopharmaceutical research, development and testing being product testing services; drug discovery services; product development, namely, drug development services; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; scientific research and development of molecules for therapeutic purposes; consultancy, advisory and information services in relation to all the aforesaid services
Owner
Prosecution history
- 02 Jun 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 10 May 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 10 May 2024 — FINAL DISPOSITION PROCESSED
- 06 May 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 21 Nov 2023 — NOTIFICATION PROCESSED BY IB
- 21 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Nov 2023 — PUBLISHED FOR OPPOSITION
- 01 Nov 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 01 Nov 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 01 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Oct 2023 — EXAMINER'S AMENDMENT ENTERED
- 16 Oct 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED